Genetic modifiers of age at onset for amyotrophic lateral sclerosis: a genome-wide association study.

These findings improve the current knowledge of the genetic and environmental etiology of AAO of ALS, and provide a novel target CTIF for further research on ALS pathogenesis and potential therapeutic options to delay the disease onset. This article is protected by copyright. All rights reserved.